1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I studies of anti-ENPP3 antibody drug conjugates (ADCs) in advanced refractory renal cell carcinomas (RRCC)
    Meeting Abstract

    Thompson, J. A.; Motzer, R.; Molina, A. M.; Choueiri, T. K.; Heath, E. I.; Kollmannsberger, C. K.; Redman, B. G.; Sangha, R. S.; Ernst, D. S.; Pili, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of radium-223 dichloride (Ra-223) on pain from US EAP
    Meeting Abstract

    Sweeney, C.; Sartor, A. O.; Vogelzang, N. J.; Shore, N. D.; Cislo, P.; Bangerter, K.; Morris, M. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identifying actionable mutations in uterine leiomyosarcoma
    Meeting Abstract

    Soumerai, T.; Hyman, D. M.; Murali, R.; Zehir, A.; O'Cearbhaill, R. E.; Arcila, M. E.; Aghajanian, C.; Soslow, R. A.; Solit, D. B.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Externally validated improved 5-factor prognostic model in patients (pts) receiving salvage systemic therapy for advanced urothelial carcinoma (UC)
    Meeting Abstract

    Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Mullane, S. A.; Niegisch, G.; Albers, P.; Necchi, A.; di Lorenzo, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases
    Meeting Abstract

    Schrader, K. A.; Cheng, D. T.; Vijai, J.; Prasad, M.; Walsh, M.; Zehir, A.; Thomas, T.; Benayed, R.; Stadler, Z. K.; Ashraf, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Scher, H. I.; Morris, M. J.; Stadler, W. M.; Higano, C. S.; Halabi, S.; Smith, M. R.; Basch, E. M.; Fizazi, K.; Ryan, C. J.; Antonarakis, E. S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Ra-223 experience in pretreated patients: EAP setting
    Meeting Abstract

    Sartor, A. O.; Fernandez, D. C.; Morris, M. J.; Iagaru, A.; Brown, A.; Almeida, F.; Sweeney, C.; Smith, M. R.; Dicker, A.; Wong, Y. N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Skeletal morbidities in the prostate cancer (PC) patient
    Meeting Abstract

    Ruppert, L. M.; Scher, H. I.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase 3 randomized, placebo-controlled double-blind study of ARN-509 plus abiraterone acetate (AA) in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Attard, G.; Efstathiou, E.; Yu, M. K.; Griffin, T. W.; Todd, M. B.; Wu, D.; Kheoh, T.; Zhao, X.; Saad, F.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Updated survival results from a randomized, dose-ranging phase II study of nivolumab (NIVO) in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Plimack, E. R.; Hammers, H. J.; Rini, B. I.; McDermott, D. F.; Redman, B.; Kuzel, T.; Harrison, M. R.; Vaishampayan, U. N.; Drabkin, H. A.; George, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save